A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data

A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data

AbstractBackground Castration-resistant prostate cancer (CRPC) represents one type of advanced prostate cancer (PCa) with a median survival time of 1–2 years. Currently, there is a lack of reliable gene panels in predicting hormone treatment (HT) responses due to limited knowledge of CRPC-specific t...

Full description

Bibliographic Details
Main Authors: Juanlan Huang, Dale Liu, Jun Li, Jing Xu, Shaowei Dong, Hao Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
CRPC
hormone-treatment
12-gene panel
combined analysis
scRNAseq data
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2260387

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2260387

Similar Items